Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: RAS MUTATION, . Treffer: 66

2022

Amini, N; Andreatos, N; Margonis, GA; Buettner, S; Wang, J; Galjart, B; Wagner, D; Sasaki, K; Angelou, A; Sun, J; Kamphues, C; Beer, A; Morioka, D; Løes, IM; Antoniou, E; Imai, K; Pikoulis, E; He, J; Kaczirek, K; Poultsides, G; Verhoef, C; Lønning, PE; Endo, I; Baba, H; Kornprat, P; NAucejo, F; Kreis, ME; Christopher, WL; Weiss, MJ; Safar, B; Burkhart, RA Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?
J Hepatobiliary Pancreat Sci. 2022; 29(4): 417-427. Doi: 10.1002/jhbp.1054
Web of Science PubMed FullText FullText_MUG

 

Boos, SL; Loevenich, LP; Vosberg, S; Engleitner, T; Öllinger, R; Kumbrink, J; Rokavec, M; Michl, M; Greif, PA; Jung, A; Hermeking, H; Neumann, J; Kirchner, T; Rad, R; Jung, P Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
Cell Mol Gastroenterol Hepatol. 2022; 13(2): 517-540. Doi: 10.1016/j.jcmgh.2021.10.008 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Geissler, K; Jäger, E; Barna, A; Gurbisz, M; Marschon, R; Graf, T; Nösslinger, T; Pfeilstöcker, M; Machherndl-Spandl, S; Stauder, R; Zebisch, A; Sill, H; Öhler, L; Kusec, R; Hoermann, G; Valent, P Multistep pathogenesis of chronic myelomonocytic leukemia in patients.
Eur J Haematol. 2022; 109(1):50-57 Doi: 10.1111/ejh.13768 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Meinhardt, AL; Munkhbaatar, E; Höckendorf, U; Dietzen, M; Dechant, M; Anton, M; Jacob, A; Steiger, K; Weichert, W; Brcic, L; McGranahan, N; Branca, C; Kaufmann, T; Dengler, MA; Jost, PJ The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner.
Oncogene. 2022; 41(9):1376-1382 Doi: 10.1038/s41388-021-02161-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wussmann, M; Groeber-Becker, FK; Riedl, S; Alihodzic, D; Padaric, D; Gerlitz, L; Stallinger, A; Liegl-Atzwanger, B; Zweytick, D; Rinner, B In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis
BIOMEDICINES. 2022; 10(11): 2961 Doi: 10.3390/biomedicines10112961 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2021

Brcic, I; Dawson, H; Gröchenig, HP; Högenauer, C; Kashofer, K Serrated Lesions in Inflammatory Bowel Disease: Genotype-Phenotype Correlation.
Int J Surg Pathol. 2021; 29(1):46-53 Doi: 10.1177/1066896920963798
Web of Science PubMed FullText FullText_MUG

 

Kamphues, C; Andreatos, N; Kruppa, J; Buettner, S; Wang, J; Sasaki, K; Wagner, D; Morioka, D; Fitschek, F; Løes, IM; Imai, K; Sun, J; Poultsides, G; Kaczirek, K; Lønning, PE; Endo, I; Baba, H; Kornprat, P; Aucejo, FN; Wolfgang, CL; Kreis, ME; Weiss, MJ; Margonis, GA The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study.
J Surg Oncol. 2021; 123(4):939-948 Doi: 10.1002/jso.26361 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Liotta, L; Lange, S; Maurer, HC; Olive, KP; Braren, R; Pfarr, N; Burger, S; Muckenhuber, A; Jesinghaus, M; Steiger, K; Weichert, W; Friess, H; Schmid, R; Algül, H; Jost, PJ; Ramser, J; Fischer, C; Quante, AS; Reichert, M; Quante, M PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer.
JCI Insight. 2021; 6(8): Doi: 10.1172/jci.insight.141532 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Margonis, GA; Amini, N; Buettner, S; Kim, Y; Wang, J; Andreatos, N; Wagner, D; Sasaki, K; Beer, A; Kamphues, C; Morioka, D; Løes, IM; Imai, K; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Burkhart, R; Endo, I; Baba, H; Mischinger, HJ; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
Ann Surg. 2021; 273(6):1165-1172 Doi: 10.1097/SLA.0000000000003504
Web of Science PubMed FullText FullText_MUG

 

Najumudeen, AK; Ceteci, F; Fey, SK; Hamm, G; Steven, RT; Hall, H; Nikula, CJ; Dexter, A; Murta, T; Race, AM; Sumpton, D; Vlahov, N; Gay, DM; Knight, JRP; Jackstadt, R; Leach, JDG; Ridgway, RA; Johnson, ER; Nixon, C; Hedley, A; Gilroy, K; Clark, W; Malla, SB; Dunne, PD; Rodriguez-Blanco, G; Critchlow, SE; Mrowinska, A; Malviya, G; Solovyev, D; Brown, G; Lewis, DY; Mackay, GM; Strathdee, D; Tardito, S; Gottlieb, E; Takats, Z; Barry, ST; Goodwin, RJA; Bunch, J; Bushell, M; Campbell, AD; Sansom, OJ, , CRUK, Rosetta, Grand, Challenge, Consortium The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.
Nat Genet. 2021; 53(1):16-26 Doi: 10.1038/s41588-020-00753-3
Web of Science PubMed FullText FullText_MUG

 

Sasaki, K; Gagnière, J; Dupré, A; Ardiles, V; O'Connor, JM; Wang, J; Moro, A; Morioka, D; Buettner, S; Gau, L; Ribeiro, M; Wagner, D; Andreatos, N; Løes, IM; Fitschek, F; Kaczirek, K; Lønning, PE; Kornprat, P; Poultsides, G; Kamphues, C; Imai, K; Baba, H; Endo, I; Kwon, CHD; Aucejo, FN; de, Santibañes, E; Kreis, ME; Margonis, GA Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH-MSK scores.
J Hepatobiliary Pancreat Sci. 2021; 28(7):581-592 Doi: 10.1002/jhbp.963
Web of Science PubMed FullText FullText_MUG

 

Schneider, R; Gademann, G; Ochel, HJ; Neumann, K; Jandrig, B; Hass, P; Walke, M; Schostak, M; Brunner, T; Christoph, F Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145.
Radiat Oncol. 2021; 16(1): 137 Doi: 10.1186/s13014-021-01859-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Unseld, M; Belic, J; Pierer, K; Zhou, Q; Moser, T; Bauer, R; Piringer, G; Gerger, A; Siebenhüner, A; Speicher, M; Heitzer, E; Prager, GW A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
Int J Cancer. 2021; 148(6):1452-1461 Doi: 10.1002/ijc.33303 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Arriga, R; Caratelli, S; Lanzilli, G; Ottaviani, A; Cenciarelli, C; Sconocchia, T; Spagnoli, GC; Iezzi, G; Roselli, M; Lauro, D; Coppola, A; Dotti, G; Ferrone, S; Sconocchia, G CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.
Int J Cancer. 2020; 146(9):2531-2538 Doi: 10.1002/ijc.32618 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fakler, F; Aykutlu, U; Brcic, L; Eidenhammer, S; Thueringer, A; Kashofer, K; Kulka, J; Timens, W; Popper, H Atypical goblet cell hyperplasia occurs in CPAM 1, 2, and 3, and is a probable precursor lesion for childhood adenocarcinoma.
Virchows Arch. 2020; 476(6):843-854 Doi: 10.1007/s00428-019-02732-4
Web of Science PubMed FullText FullText_MUG

 

Timar, J; Kashofer, K Molecular epidemiology and diagnostics of KRAS mutations in human cancer.
Cancer Metastasis Rev. 2020; 39(4):1029-1038 Doi: 10.1007/s10555-020-09915-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Liebs, S; Keilholz, U; Kehler, I; Schweiger, C; Haybäck, J; Nonnenmacher, A Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
Cancer Med. 2019; 8(8):3761-3769 Doi: 10.1002/cam4.2219 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Margonis, GA; Amini, N; Andreatos, N; Sasaki, K; McVey, J; Mirza, MB; Warner, S; Buettner, S; Barbon, C; Wang, J; Pulvirenti, A; Angelou, A; Kamphues, C; Antoniou, E; Pikoulis, E; Pawlik, TM; Kaczirek, K; Poultsides, G; Wagner, D; Endo, I; Imai, K; Aucejo, F; Kreis, ME; Wolfgang, CL; Weiss, MJ KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases.
HPB (Oxford). 2019; 21(11):1527-1534 Doi: 10.1016/j.hpb.2019.03.368 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Margonis, GA; Buettner, S; Andreatos, N; Wagner, D; Sasaki, K; Barbon, C; Beer, A; Kamphues, C; Løes, IM; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Cameron, JL; Mischinger, HJ; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
ANN SURG. 2019; 269(6): 1129-1137. Doi: 10.1097/SLA.0000000000002664
Web of Science PubMed FullText FullText_MUG

 

Schumacher, D; Andrieux, G; Boehnke, K; Keil, M; Silvestri, A; Silvestrov, M; Keilholz, U; Haybaeck, J; Erdmann, G; Sachse, C; Templin, M; Hoffmann, J; Boerries, M; Schäfer, R; Regenbrecht, CRA Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures.
PLoS Genet. 2019; 15(3):e1008076-e1008076 Doi: 10.1371/journal.pgen.1008076 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Smolle, MA; Kashofer, K; Riedl, JM; Stotz, M; Gerger, A Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature.
Anticancer Res. 2019; 39(2): 847-852. Doi: 10.21873/anticanres.13184
Web of Science PubMed FullText FullText_MUG

 

2018

Griewank, KG; Wiesner, T; Murali, R; Pischler, C; Müller, H; Koelsche, C; Möller, I; Franklin, C; Cosgarea, I; Sucker, A; Schadendorf, D; Schaller, J; Horn, S; Brenn, T; Mentzel, T Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles.
Mod Pathol. 2018; 31(3): 418-428. Doi: 10.1038/modpathol.2017.146 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Margonis, GA; Buettner, S; Andreatos, N; Kim, Y; Wagner, D; Sasaki, K; Beer, A; Schwarz, C; Løes, IM; Smolle, M; Kamphues, C; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Cameron, JL; Burkhart, RA; Gerger, A; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
JAMA Surg. 2018; 153(7): e180996-e180996. Doi: 10.1001/jamasurg.2018.0996 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Margonis, GA; Buettner, S; Andreatos, N; Wagner, D; Sasaki, K; Barbon, C; Beer, A; Kamphues, C; Løes, IM; He, J; Pawlik, TM; Kaczirek, K; Poultsides, G; Lønning, PE; Cameron, JL; Mischinger, HJ; Aucejo, FN; Kreis, ME; Wolfgang, CL; Weiss, MJ Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
Ann Surg. 2018; Doi: 10.1097/SLA.0000000000002664
PubMed FullText FullText_MUG

 

Zaric, B; Brcic, L; Buder, A; Brandstetter, A; Buresch, JO; Traint, S; Kovacevic, T; Stojsic, V; Perin, B; Pirker, R; Filipits, M PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma.
Clin Lung Cancer. 2018; 19(6):e957-e963-e957-e963 Doi: 10.1016/j.cllc.2018.08.014
Web of Science PubMed FullText FullText_MUG

 

2017

Fakhruddin, N; Jabbour, M; Novy, M; Tamim, H; Bahmad, H; Farhat, F; Zaatari, G; Aridi, T; Kriegshauser, G; Oberkanins, C; Mahfouz, R BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases.
Sci Rep. 2017; 7(1): 4666-4666. Doi: 10.1038/s41598-017-04948-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rinner, B; Gandolfi, G; Meditz, K; Frisch, MT; Wagner, K; Ciarrocchi, A; Torricelli, F; Koivuniemi, R; Niklander, J; Liegl-Atzwanger, B; Lohberger, B; Heitzer, E; Ghaffari-Tabrizi-Wizsy, N; Zweytick, D; Zalaudek, I MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line.
Sci Rep. 2017; 7(1):2098-2098 Doi: 10.1038/s41598-017-02197-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Saraggi, D; Salmaso, R; Valentini, E; Munari, G; Vindigni, V; Rugge, M; Fassan, M; Cerroni, L Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver.
Pathol Res Pract. 2017; 213(7):860-862 Doi: 10.1016/j.prp.2017.03.012 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2016

Bonin, S; Donada, M; Bussolati, G; Nardon, E; Annaratone, L; Pichler, M; Chiaravalli, AM; Capella, C; Hoefler, G; Stanta, G A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
Tumour Biol. 2016; 37(6):7295-7303 Doi: 10.1007/s13277-015-4543-3
Web of Science PubMed FullText FullText_MUG

 

Brcic, L; Jakopovic, M; Misic, M; Seiwerth, F; Kern, I; Smojver-Jezek, S; Quehenberger, F; Samarzija, M; Seiwerth, S Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia.
Diagn Pathol. 2016; 11(1):90-90 Doi: 10.1186/s13000-016-0544-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Busam, KJ; Vilain, RE; Lum, T; Busam, JA; Hollmann, TJ; Saw, RP; Coit, DC; Scolyer, RA; Wiesner, T Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation.
Am J Surg Pathol. 2016; 40(6):786-795 Doi: 10.1097/PAS.0000000000000611 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

van de Nes, J; Gessi, M; Sucker, A; Möller, I; Stiller, M; Horn, S; Scholz, SL; Pischler, C; Stadtler, N; Schilling, B; Zimmer, L; Hillen, U; Scolyer, RA; Buckland, ME; Lauriola, L; Pietsch, T; Waha, A; Schadendorf, D; Murali, R; Griewank, KG Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
J NEURO-ONCOL. 2016; 127(3): 435-444. Doi: 10.1007/s11060-015-2052-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wiesner, T; Kutzner, H; Cerroni, L; Mihm, MC; Busam, KJ; Murali, R Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Pathology. 2016; 48(2):113-131 Doi: 10.1016/j.pathol.2015.12.007 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Geles, A; Gruber-Moesenbacher, U; Quehenberger, F; Manzl, C; Al Effah, M; Grygar, E; Juettner-Smolle, F; Popper, HH Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival.
Virchows Arch. 2015; 467(6):675-686 Doi: 10.1007/s00428-015-1852-2
Web of Science PubMed FullText FullText_MUG

 

Grabner, B; Schramek, D; Mueller, KM; Moll, HP; Svinka, J; Hoffmann, T; Bauer, E; Blaas, L; Hruschka, N; Zboray, K; Stiedl, P; Nivarthi, H; Bogner, E; Gruber, W; Mohr, T; Zwick, RH; Kenner, L; Poli, V; Aberger, F; Stoiber, D; Egger, G; Esterbauer, H; Zuber, J; Moriggl, R; Eferl, R; Győrffy, B; Penninger, JM; Popper, H; Casanova, E Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.
Nat Commun. 2015; 6(4):6285-6285 Doi: 10.1038/ncomms7285 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kaczirek, K; Ciuleanu, TE; Vrbanec, D; Marton, E; Messinger, D; Liegl-Atzwanger, B; Wrba, F; Knittelfelder, R; Lindner, E; Zielinski, CC; Streubel, B; Brodowicz, T FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.
Clin Colorectal Cancer. 2015; 14(2):91-98 Doi: 10.1016/j.clcc.2014.12.003
Web of Science PubMed FullText FullText_MUG

 

Langner, C Serrated and non-serrated precursor lesions of colorectal cancer.
Dig Dis. 2015; 33(1):28-37 Doi: 10.1159/000366032
Web of Science PubMed FullText FullText_MUG

 

Wiesner, T; Kutzner, H Morphological and genetic aspects of Spitz tumors].
Pathologe. 2015; 36(1): 37-43. Doi: 10.1007/s00292-014-1984-1
Web of Science PubMed FullText FullText_MUG

 

Zopf, A; Raim, R; Danzer, M; Niklas, N; Spilka, R; Pröll, J; Gabriel, C; Nechansky, A; Roucka, M Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection.
Biotechniques. 2015; 58(3):126-134 Doi: 10.2144/000114264 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Pichler, M; Winter, E; Ress, AL; Bauernhofer, T; Gerger, A; Kiesslich, T; Lax, S; Samonigg, H; Hoefler, G miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
J Clin Pathol. 2014; 67(3):198-203 Doi: 10.1136/jclinpath-2013-201904
Web of Science PubMed FullText FullText_MUG

 

Rau, TT; Agaimy, A; Gehoff, A; Geppert, C; Jung, K; Knobloch, K; Langner, C; Lugli, A; Groenbus-Lurkin, I; Nagtegaal, ID; Rüschoff, J; Saegert, X; Sarbia, M; Schneider-Stock, R; Vieth, M; Zwarthoff, EC; Hartmann, A Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics.
Virchows Arch. 2014; 464(6):663-672 Doi: 10.1007/s00428-014-1569-7
Web of Science PubMed FullText FullText_MUG

 

Schrama, D; Groesser, L; Ugurel, S; Hafner, C; Pastrana, DV; Buck, CB; Cerroni, L; Theiler, A; Becker, JC Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations.
JAMA Dermatol. 2014; 150(11):1180-1186 Doi: 10.1001/jamadermatol.2014.1116 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Dijkstra, JR; Heideman, DA; Meijer, GA; Boers, JE; 't Hart, NA; Diebold, J; Hirschmann, A; Hoefler, G; Winter, G; Miltenberger-Miltenyi, G; Pereira, SV; Richman, SD; Quirke, P; Rouleau, EL; Guinebretiere, JM; Tejpar, S; Biesmans, B; van Krieken, JH KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance.
Virchows Arch. 2013; 462(1):39-46 Doi: 10.1007/s00428-012-1356-2
Web of Science PubMed FullText FullText_MUG

 

Griewank, KG; Westekemper, H; Murali, R; Mach, M; Schilling, B; Wiesner, T; Schimming, T; Livingstone, E; Sucker, A; Grabellus, F; Metz, C; Süsskind, D; Hillen, U; Speicher, MR; Woodman, SE; Steuhl, KP; Schadendorf, D Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Clin Cancer Res. 2013; 19(12):3143-3152 Doi: 10.1158/1078-0432.CCR-13-0163 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moldvay, J; Barbai, T; Bogos, K; Piurko, V; Fillinger, J; Popper, HH; Tímár, J EGFR autophosphorylation but not protein score correlates with histologic and molecular subtypes in lung adenocarcinoma.
Diagn Mol Pathol. 2013; 22(4):204-209 Doi: 10.1097/PDM.0b013e3182936957
Web of Science PubMed FullText FullText_MUG

 

2012

Dijkstra, JR; Opdam, FJ; Boonyaratanakornkit, J; Schönbrunner, ER; Shahbazian, M; Edsjö, A; Hoefler, G; Jung, A; Kotsinas, A; Gorgoulis, VG; Lpez-Ros, F; de Stricker, K; Rouleau, E; Biesmans, B; van Krieken, JH Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysis.
J Mol Diagn. 2012; 14(3):187-191 Doi: 10.1016/j.jmoldx.2012.01.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zebisch, A; Wölfler, A; Fried, I; Wolf, O; Lind, K; Bodner, C; Haller, M; Drasche, A; Pirkebner, D; Matallanas, D; Rath, O; Blyth, K; Delwel, R; Taskesen, E; Quehenberger, F; Kolch, W; Troppmair, J; Sill, H Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia.
Leukemia. 2012; 26(8):1842-1849 Doi: 10.1038/leu.2012.61 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Betge, J; Pollheimer, MJ; Schlemmer, A; Hoefler, G; Langner, C Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
Oncol Rep. 2011; 26(3):567-575 Doi: 10.3892/or.2011.1346 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gantner, S; Wiesner, T; Cerroni, L; Lurkin, I; Zwarthoff, EC; Landthaler, M; Hafner, C Absence of BRAF and HRAS mutations in eruptive Spitz naevi
BRIT J DERMATOL. 2011; 164(4): 873-877. Doi: 10.1111/j.1365-2133.2011.10210.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Kriegshäuser, G; Auner, V; Schuster, E; Holzer, B; Oberkanins, C; Horvat, R; Speiser, P; Zeillinger, R KRAS mutation analysis in genomic DNA isolated from formalin-fixed paraffin-embedded ovarian tissue: evaluation of a strip-based reverse-hybridisation assay.
J Clin Pathol. 2011; 64(3): 252-256. Doi: 10.1136/jcp.2010.081414
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum